|
Stock futures fell early Thursday after the Fed said there's "quite a bit of room" to raise rates before hurting the labor market.
|
RELATED ARTICLES | | | | |
|
Relationship between digital and traditional markets has tightened since 2020, research shows
|
|
 Intel Corp. executives expect profit margins to remain pressured in the long term as the chip maker builds out manufacturing capacity, leading to a disappointing earnings guidance that dinged the company's stock Wednesday afternoon.
|
|
 Northfield (NFBK) delivered earnings and revenue surprises of 13.33% and 4.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
|
|
Shares gained about 12% in after-hours trading on Wednesday after the experience-management platform operator released fourth-quarter results.
|
|
A "titanic battle" between stock-market bulls and bears looms as the Federal Reserve prepares to lift interest rates, says Deutsche Bank's Alan Ruskin.
|
|
The Dow, which had been up roughly 600 points, ends the session with a 130-point loss after the central bank spells out its plan for soaring inflation.
|
|
 Clorox Co. shares fell 4.2% in Wednesday trading after the consumer cleaning products company was downgraded to underperform from neutral at Credit Suisse based on concern that the skyrocketing growth from early in the pandemic has started to wane. Analysts maintained their $160 target price. Sales for fiscal year ending June 2021 reached $7.34 billion, up from $6.72 billion for the fiscal year ending June 2020. Sales for the fiscal first quarter fell to $1.81 billion from $1.92 billion the previous year. "Nearly two years into the pandemic, Clorox is a larger company that can grow faster," the note said. "If consumption continues to revert toward pre-pandemic levels, $500 million in company sales may still be at risk." Analysts also highlight pricing uncertainty and the impact on margins. "If consumption weakens further amid high input cost inflation, a drop in volumes could result in material deleverage to margins," the note said. Clorox is scheduled to report fiscal second-quarter results on Feb. 3, according to a FactSet calendar. Clorox stock has tumbled 21.7% over the past year while the S&P 500 index has gained nearly 15%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Palladium futures climbed sharply on Wednesday, with prices settling at their highest since September, with rising tensions over Ukraine prompting concerns of a possible disruption to supplies of the metal from Russia, which is the world's largest producer. "An all-out conflict with Russia would exasperate an already critical supply issue in the palladium space," said Chris Blasi, president of Neptune Global. March palladium climbed $161.70, or 7.4%, to settle at $2,350.60 an ounce on Comex, the highest most-active contract finish since Sept. 7, according to FactSet data.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
The managers at Primecap Oydssey Growth (POGRX) like to focus on what they do best - pick stocks - and they typically don't talk to reporters.
So once a year, when the fund's annual report comes out, we read every word. Over the past 12 months, Kiplinger 25 member Odyssey Growth gained 12.7%, which trailed the 24.7% gain in the S&P 500.
SEE MORE 2022's Best Mutual Funds in 401(k) Retirement Plans
We're not worried. Short-term returns can be instructive and add some perspective, but long-term performance matters most.
And over the long haul, Primecap's managers have not disappointed shareholders. The fund's 15-year annualized return, 11.3%, beat the S&P 500 by an average of 0.7 percentage point per year.
But 2021 was a win-some, lose-some year for the fund. Some of the fund's top 10 holdings generated market-beating returns. Shares in banking giant Morgan Stanley (MS), for instance, gained 42% over the past 12 months. Other top holdings jumped even higher: Eli Lilly (LLY) was up 59%; Alphabet (GOOGL), 54%; and Microsoft (MSFT), 45%.
Biotech Stocks Stumble
But the fund holds 15% of assets in biotech stocks - a chunk, relative to the 2% exposure in the S&P 500 - which pressured results.
Biotechnology w
|
|
The World Health Organization said Wednesday the number of new COVID cases recorded in the week through Jan. 23 rose 5% to more than 21 million, the most reported on a weekly basis since the start of the pandemic. The number reflects the speed with which the highly contagious omicron variant has spread. The agency said omicron continues to pose a lower risk of severe disease and death than other variants and people who are vaccinated are protected from both. "However, due to the very high numbers of cases, many countries have seen a significant increase in the incidence of hospitalization, putting pressure on healthcare systems," the WHO said in its weekly epidemiological update. Maria Van Kerkhove, WHO COVID-19 technical lead, said in a livestream Tuesday that almost three billion people have still not received a first vaccine dose, leaving the risk of new variants emerging that may prove vaccine-resistant. In the U.S., case numbers are retreating from their early January peak. The U.S. is averaging 652,278 cases a day, according to a New York Times tracker, down 14% from two weeks ago. Hospitalizations at an average of 155,247 remain high, however, and deaths are averaging more than 2,362 a day, the most since last winter.
On a global basis, the total tally for COVID-19 cases hiked up above 358.9 million and the death toll rose above 5.61 million, according to data aggregated by Johns Hopkins University. The U.S. leads the world with a total COVID-19 case count of 72 million and death toll of 872,126.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
As the war for talent rages on, the bank with more than $2 trillion in assets is now expanding access to its stock program to hang onto its workforce.
|
|
An early market rally gave way to a broad slide for stocks and a surge in bond yields Wednesday after the Federal Reserve signaled it plans to raise interest rates "soon."
|
|
Stocks Turn Lower After Fed Announcement on Interest Rates The Wall Street JournalFed holds rates at near zero, tees up interest rate increase to quell inflation Yahoo FinanceFed signals rate hike to curb inflation could come 'soon' Fox BusinessThe Fed is likely to signal a March interest rate hike and that further policy tightening is coming CNBCHere are the many reasons why the Federal Reserve won't raise interest rates as much as expected MarketWatchView Full Coverage on Google News
|
|
Oil prices finished lower on Friday, but scored a fifth consecutive weekly rise. "Crude prices may not have a one-way ticket to $100 oil, but the supply-side fundamentals certainly support that could happen by the summer," said Edward Moya, senior market analyst at OANDA. "The next few trading sessions could be difficult for energy traders as oil prices may move more so on investor positioning ahead of Wednesday's FOMC policy decision and over a handful of brewing geopolitical risks, that include Russia-Ukraine tensions, Iran nuclear talks, and developments with global handling over North Korea." March West Texas Intermediate crude fell 41 cents, or 0.5%, to settle at $85.14 a barrel on the New York Mercantile Exchange. The U.S. benchmark, based on the front-month contract, rose 2.2% for the week, according to Dow Jones Market Data.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
